Ilias Houda, MD, PhD Candidate, on Results of an EORTC Survey on NSCLC Resectability

October 04, 2023 By The ASCO Post Staff

Ilias Houda, MD, PhD Candidate, of Amsterdam University Medical Centers, discusses the differing opinions of thoracic surgeons when it comes to resection for stage III non–small cell lung cancer (NSCLC). The international EORTC survey showed there is no consensus, although respondents were more likely to consider some stage III TNM combinations to be potentially resectable.

Related Content